Sign In
Buy IPA
$1.62
+0 (+0%)
At Close: Jan 16, 2026
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
09:00am, Monday, 21'st Oct 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, tod
Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District
02:54pm, Wednesday, 16'th Oct 2024
LOS ANGELES--(BUSINESS WIRE)-- #apartmentbrokers--Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District.
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
09:00am, Thursday, 26'th Sep 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript
01:46pm, Monday, 16'th Sep 2024
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q1 2025 Earnings Conference Call September 16, 2024 10:30 AM ET Company Participants Jennifer Bath - CEO Kristin Taylor - CFO Conference Call Participants S
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates
11:26am, Monday, 16'th Sep 2024
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.09.
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024
09:11am, Monday, 09'th Sep 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
09:00am, Monday, 26'th Aug 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), is pleased to announce that it will be attending H.C. Wainwright
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements
08:00pm, Friday, 23'rd Aug 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutics company, announced today that the C
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutics company, today announced a groundbr
ImmunoPrecise Antibodies Ltd. (IPA) Q4 2024 Earnings Call Transcript
08:36pm, Monday, 29'th Jul 2024
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q4 2024 Earnings Conference Call July 29, 2024 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer Kristin Taylor - Chief Financial Off
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates
10:55am, Monday, 29'th Jul 2024
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.10.
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) today announces the rescheduling of its full year fiscal 2024 financial r
SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC
07:00am, Friday, 19'th Jul 2024
ATLANTA, July 19, 2024 (GLOBE NEWSWIRE) -- Calling all 17s1! SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), one of the largest craft brewers in the Southeast and a subsidia
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, tod
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
07:00am, Wednesday, 12'th Jun 2024
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), a leader in AI-driven biotherapeutic rese
